Artemin, a Member of the Glial Cell Line-derived Neurotrophic Factor Family of Ligands, Is HER2-regulated and Mediates Acquired Trastuzumab Resistance by Promoting Cancer Stem Cell-like Behavior in Mammary Carcinoma Cells-Reference-Cited by-同舟云学术

Artemin, a Member of the Glial Cell Line-derived Neurotrophic Factor Family of Ligands, Is HER2-regulated and Mediates Acquired Trastuzumab Resistance by Promoting Cancer Stem Cell-like Behavior in Mammary Carcinoma Cells

Published:2014-06 Issue:23 Volume:289 Page:16057-16071
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Ding Keshuo,Banerjee Arindam,Tan Sheng,Zhao JunSong,Zhuang Qian,Li Rui,Qian Pengxu,Liu Suling,Wu Zheng-Sheng,Lobie Peter E.,Zhu Tao

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference52 articles.

1. Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases;Stern;Breast Cancer Res,2000

2. Mechanisms of resistance to trastuzumab and novel therapeutic strategies in HER2-positive breast cancer;Wong;Int. J. Breast Cancer,2012

3. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population;Korkaya;Mol. Cell,2012

4. Emerging approaches for treating HER2-positive metastatic breast cancer beyond trastuzumab;Gradishar;Ann. Oncol,2013

5. Novel targeted therapies to overcome trastuzumab resistance in HER2-overexpressing metastatic breast cancer;Huang;Curr. Drug Targets,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and Challenges in Cancer Stem Cells for Onco-Therapeutics;Stem Cells International;2023-12-06

2. Small molecule inhibition of TFF3 overcomes tamoxifen resistance and enhances taxane efficacy in ER+ mammary carcinoma;Cancer Letters;2023-11

3. JHDM1D-AS1-driven inhibition of miR-940 releases ARTN expression to induce breast carcinogenesis;Clinical and Translational Oncology;2023-03-02

4. Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer;Frontiers in Genetics;2022-11-14

5. Evolution of gene expression signature in mammary gland stem cells from neonatal to old mice;Cell Death & Disease;2022-04-12